Clinical trialNo phase (not a drug trial)Suspended
RCT of Mobile Apps & FitBit v. Usual Care
Randomized Clinical Trial of FitBit and Mobile Apps Versus Usual Care to Improve Post-Operative Outcomes After GI Cancer Surgery
- Outcome
- Stopped earlyStudy is paused for interim analysis. (Other)
- Phase
- No phase (not a drug trial)
- Status
- Suspended
- Study type
- Interventional
- Start
- 31 May 2017
- Expected end
- March 2027
- Enrollment
- 107 participants
- Sites
- 1
- Primary outcomes
- Readmission rate
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 28 September 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
Detailed description public domain (ClinicalTrials.gov)
Patients will be randomized to 1) standard of care or 2) to use our mobile app with standard care. The mobile app will collect information on patients' daily physical activity patterns and health status data for clinicians using smartphone mobile technology applications. The investigators believe that by tracking information on patients, the investigators may be able to intervene sooner and prevent a delay in care.